ATA42190A - Gelatinekapseln mit einem gehalt an ranitidin (salz) - Google Patents

Gelatinekapseln mit einem gehalt an ranitidin (salz)

Info

Publication number
ATA42190A
ATA42190A AT0042190A AT42190A ATA42190A AT A42190 A ATA42190 A AT A42190A AT 0042190 A AT0042190 A AT 0042190A AT 42190 A AT42190 A AT 42190A AT A42190 A ATA42190 A AT A42190A
Authority
AT
Austria
Prior art keywords
salt
capsules containing
gelatine capsules
containing ranitidine
ranitidine
Prior art date
Application number
AT0042190A
Other languages
English (en)
Other versions
AT401727B (de
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of ATA42190A publication Critical patent/ATA42190A/de
Application granted granted Critical
Publication of AT401727B publication Critical patent/AT401727B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0042190A 1989-02-23 1990-02-22 Gelatinekapseln mit einem gehalt an ranitidin (salz) AT401727B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA42190A true ATA42190A (de) 1996-04-15
AT401727B AT401727B (de) 1996-11-25

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0042190A AT401727B (de) 1989-02-23 1990-02-22 Gelatinekapseln mit einem gehalt an ranitidin (salz)

Country Status (26)

Country Link
US (1) US5028432A (de)
JP (1) JP2856817B2 (de)
KR (1) KR940006271B1 (de)
AT (1) AT401727B (de)
AU (1) AU629303B2 (de)
BE (1) BE1003123A3 (de)
CA (1) CA2010692C (de)
CH (1) CH680567A5 (de)
CY (1) CY1734A (de)
DE (1) DE4005650C2 (de)
DK (1) DK170209B1 (de)
FR (1) FR2643263B1 (de)
GB (2) GB8904182D0 (de)
HK (1) HK89493A (de)
HU (1) HU211930A9 (de)
IE (1) IE63179B1 (de)
IL (1) IL93490A (de)
IT (1) IT1240768B (de)
LU (1) LU87681A1 (de)
NL (1) NL193267C (de)
NZ (1) NZ232642A (de)
PH (1) PH26972A (de)
SA (1) SA90100287B1 (de)
SE (1) SE512412C2 (de)
ZA (1) ZA901348B (de)
ZW (1) ZW1790A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
JPH08510989A (ja) * 1992-10-16 1996-11-19 グラクソ、グループ、リミテッド ラニチジン組成物
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
WO2004069180A2 (en) * 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
EP1660047B1 (de) 2003-08-13 2013-11-27 Biocon Limited Mikroteilchenförmige fettsäure-salz-festdosis-formulierungen für therapeutische mittel
BR112012030037B1 (pt) 2010-06-23 2017-06-27 Colgate-Palmolive Company Oral hygiene composition, use and article
MY163496A (en) 2010-12-20 2017-09-15 Colgate Palmolive Co Non-aqueous oral care composition containing dental occlusion actives
EP2654672B1 (de) 2010-12-20 2017-03-08 Colgate-Palmolive Company Mit gelatin verkapselte mundpflegezusammensetzung enthaltend okkludierende wirkstoffe, hydrophobe viskositätsmodifizierer und einen ölträger
US9320690B2 (en) 2010-12-20 2016-04-26 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
EP3534880B1 (de) * 2016-11-01 2022-05-18 Johnson & Johnson Consumer Inc. Flüssige orale pharmazeutische zubereitung enthaltend einen histamin-h2-rezeptor-antagonisten und ein antacidum
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (de) * 1980-05-17 1981-11-25 FISONS plc Mischungen, Salze, Packungen und pharmazeutische Zusammensetzungen mit Gehalt an 5-(2-Hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carbonsäure oder einem Derivat derselben und einem H2-Rezeptoren antagonisierenden Antihistamin
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
BE896711A (fr) * 1982-05-14 1983-09-01 Richter Gedeon Vegyeszet Compositions pharmaceutiques anti-ulceres.
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
WO1985000516A1 (en) * 1983-08-01 1985-02-14 R. P. Scherer Corporation Sustained release method and product
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CH679373A5 (de) * 1988-09-20 1992-02-14 Glaxo Group Ltd

Also Published As

Publication number Publication date
DK48090D0 (da) 1990-02-22
CY1734A (en) 1994-05-06
HK89493A (en) 1993-09-03
PH26972A (en) 1992-12-28
KR900012612A (ko) 1990-09-01
AU5007390A (en) 1990-08-30
IT9047659A1 (it) 1991-08-22
GB9004016D0 (en) 1990-04-18
SE9000625D0 (sv) 1990-02-22
SE512412C2 (sv) 2000-03-13
SA90100287B1 (ar) 1999-08-15
NL9000428A (nl) 1990-09-17
CA2010692A1 (en) 1990-08-23
KR940006271B1 (ko) 1994-07-14
FR2643263A1 (fr) 1990-08-24
ZA901348B (en) 1991-03-27
GB2229094B (en) 1993-01-06
DE4005650C2 (de) 1999-03-25
CH680567A5 (de) 1992-09-30
AT401727B (de) 1996-11-25
BE1003123A3 (fr) 1991-12-03
IL93490A (en) 1994-07-31
ZW1790A1 (en) 1991-10-16
JPH03200728A (ja) 1991-09-02
US5028432A (en) 1991-07-02
IT1240768B (it) 1993-12-17
SE9000625L (sv) 1990-08-24
DE4005650A1 (de) 1990-09-06
AU629303B2 (en) 1992-10-01
FR2643263B1 (fr) 1994-09-16
DK48090A (da) 1990-08-24
IT9047659A0 (it) 1990-02-22
IE900651L (en) 1990-08-23
GB2229094A (en) 1990-09-19
JP2856817B2 (ja) 1999-02-10
IL93490A0 (en) 1990-11-29
HU211930A9 (en) 1996-01-29
NL193267B (nl) 1999-01-04
DK170209B1 (da) 1995-06-19
LU87681A1 (fr) 1991-10-08
CA2010692C (en) 1995-12-12
NZ232642A (en) 1992-07-28
IE63179B1 (en) 1995-03-22
GB8904182D0 (en) 1989-04-05
NL193267C (nl) 1999-05-06

Similar Documents

Publication Publication Date Title
ATA42190A (de) Gelatinekapseln mit einem gehalt an ranitidin (salz)
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
KR880011653U (ko) 의약용 캅셀
DK237884D0 (da) Farmaceutisk praeparat
DE69029665D1 (de) Arzneimittelbehälter enthaltende Kassette
FI883785A (fi) Kapsel foer farmaceutiskt verksamt inhaleringsaemne i ett laekemedel.
NO831186L (no) Fortilsetning for droevtyggere
BR8300391A (pt) Ponte de medicao
DK225588A (da) Farmaceutisk praeparat indeholdende et litiumsalt
FI832197L (fi) Farmaceutisk blandning
PT88447A (pt) Improved process for preparing gelatine capsules
DK58983D0 (da) Farmaceutisk praeparat
DK109887D0 (da) Farmaceutisk praeparat indeholdende antistoffer
FR2638640B1 (fr) Solution pharmaceutique
DK140983D0 (da) Flaget saltpraeparat
DK163638C (da) Farmaceutisk praeparat indeholdende den antibiotiske forbindelse cl-1957a eller et farmaceutisk salt deraf
FR2618303B1 (fr) Preparation de gelatine presentant un degre bloom eleve a partir de sous-produits de volaille
FI830617A0 (fi) 1,4-dihydropyridin-derivat, deras framstaellning och dessa innehaollande farmaceutiksa produkter
DE68912947D1 (de) Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung.
DK180883D0 (da) Fiskeemballage
NO894984D0 (no) Toert mikrobiocid preparat inneholdende et etylen-bis-ditiokarbamatsalt.
AU2698184A (en) Gelatin capsule
DE3682148D1 (de) Pharmazeutische zusammensetzung mit gehalt an dinatrium cromoglicicum und an einem mucolytikum.
FR2550514B1 (fr) Capsule inviolable
KR840005163U (ko) 약제 과립기

Legal Events

Date Code Title Description
ELA Expired due to lapse of time